GlassScriptPhysician profile
Payam Sarraf
NPI 1649273814
$1,655.80
in general payments reported to CMS, 2019-2025
23 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $21.52 · 2021: $235 · 2022: $393 · 2023: $367 · 2024: $154 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $449.28 | 2019-2024 | Collagenase Santyl, Grafix Pl, Regranex |
| Abbvie INC. | $266.15 | 2022-2025 | Dalvance |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $125.95 | 2021-2024 | Jublia |
| Osiris Therapeutics INC. | $115.44 | 2019 | |
| Stryker Corporation | $98.24 | 2021-2025 | Augment Injectable, Smart Toe |
| Orthofix Medical, INC. | $87.48 | 2019-2025 | Physio-Stim, Accelstim |
| Bioventus LLC | $70.07 | 2019-2022 | |
| Horizon Therapeutics Plc | $51.53 | 2019-2023 | Krystexxa |
| Melinta Therapeutics, LLC | $46.93 | 2019 | |
| Organogenesis INC. | $43.46 | 2023 | Puraply |
| Aap Implants INC | $40.51 | 2021-2022 | |
| Medtronic, INC. | $39.01 | 2025 | Inceptiv |
| Nalu Medical, INC. | $34.17 | 2025 | Nalu Neurostimulation System |
| Kci USA, INC. | $30.79 | 2022 | |
| Amgen INC. | $29.36 | 2024-2025 | Krystexxa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $20.76 | 2023 | Cmf |
| Pacira Pharmaceuticals Incorporated | $19.05 | 2025 | Exparel |
| Vertex Pharmaceuticals Incorporated | $18.32 | 2025 | |
| Nevro Corp. | $17.44 | 2023 | Senza |
| Merck Sharp & Dohme LLC | $15.55 | 2019 | |
| Nabriva Therapeutics, Plc | $14.00 | 2022 | |
| Hikma Pharmaceuticals USA | $11.18 | 2019 | |
| Advanced Oxygen Therapy INC. | $11.13 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Payam Sarraf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.